Versant Capital Management, Inc Amicus Therapeutics, Inc. Transaction History
Versant Capital Management, Inc
- $710 Million
- Q3 2025
A detailed history of Versant Capital Management, Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 5,266 shares of FOLD stock, worth $47,551. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,266
Previous 879
499.09%
Holding current value
$47,551
Previous $5,000
720.0%
% of portfolio
0.01%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding FOLD
# of Institutions
304Shares Held
332MCall Options Held
396KPut Options Held
249K-
Vanguard Group Inc Valley Forge, PA29.4MShares$266 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA29.1MShares$263 Million0.03% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$220 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY18MShares$163 Million1.88% of portfolio
-
William Blair Investment Management, LLC Chicago, IL14.6MShares$132 Million0.24% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.53B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...